Delayed and deferred surgery associated with cenobamate use in people with drug‐resistant focal epilepsy
Epilepsia · 2026
DOI: 10.1002/epi.70215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2026. Verfasst von Jacob Pellinen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Anticonvulsants, Epilepsies, Partial, Carbamates. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: SK Life Science.
Abstract (Originalsprache)
Objective
Cenobamate has been shown to be an effective antiseizure medication for some patients with drug‐resistant focal epilepsy being considered for epilepsy surgery. This retrospective single‐center study evaluated whether surgery was obtained within 12 months for patients who received cenobamate as a treatment during the presurgical evaluation and those who did not, comparing across years before and after cenobamate approval.
Methods
Patients undergoing surgical evaluation for drug‐resistant focal epilepsy at the University of Colorado during 2018 and 2023 who had 12 months of follow‐up data were analyzed. Comparison years were also chosen to avoid the confounding effect of the COVID‐19 pandemic on surgical volume (2020–2021). This allowed for comparison times before and after cenobamate's US Food and Drug Administration approval. The primary outcome (surgery within 12 months) was modeled with potential explanatory variables using multiple logistic regression. A p ‐value of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA.
- College of Osteopathic Medicine, Rocky Vista University, Englewood, Colorado, USA.
- SSM Health, Fond du Lac, Wisconsin, USA.
- SK Life Science, Paramus, New Jersey, USA.
- Comprehensive Epilepsy Care Center for Children and Adults, St. Louis, Missouri, USA.
- New York University Grossman School of Medicine and New York University Langone Health, New York, New York, USA.
ORCID-Profile: Jacob Pellinen, Stefan Sillau, Aimee Bui, Lesley Kaye, Louis Ferrari, William E Rosenfeld, Christopher Elder
Förderung
- SK Life Science
Zitieren
APA
Pellinen, J., Sillau, S., Bui, A., Danciutiu, A., Kaye, L., Sood, A., Ferrari, L., Rosenfeld, W. E., & Elder, C. (2026). Delayed and deferred surgery associated with cenobamate use in people with drug‐resistant focal epilepsy. Epilepsia. https://doi.org/10.1002/epi.70215
Vancouver
Pellinen J, Sillau S, Bui A, Danciutiu A, Kaye L, Sood A, et al. Delayed and deferred surgery associated with cenobamate use in people with drug‐resistant focal epilepsy. Epilepsia. 2026. doi:10.1002/epi.70215
BibTeX
@article{Pellinen2026,
author = {Pellinen, Jacob and Sillau, Stefan and Bui, Aimee and Danciutiu, Alexandra and Kaye, Lesley and Sood, Ashvin and Ferrari, Louis and Rosenfeld, William E and Elder, Christopher},
title = {Delayed and deferred surgery associated with cenobamate use in people with drug‐resistant focal epilepsy},
journal = {Epilepsia},
year = {2026},
doi = {10.1002/epi.70215}
}
EUVIMED